Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in organophosphate poisoned patients
IRCT20120215009014N610Phase 3Recruiting
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of coenzyme q10 in organophosphate poisoning, sponsored by Hamadan University of Medical Sciences. Primary endpoints: Changes in oxidative stress markers, Changes in inflammatory markers and 3 more. Started May 2026; status: recruiting.
02
Drugs
coenzyme q10
03
Conditions
organophosphate poisoning
Beyond the preview
Go deeper on IRCT20120215009014N610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N610.